HT
BMRN icon

HAP Trading’s BioMarin Pharmaceuticals BMRN Stock Holding History

HAP Trading’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-32,900
Closed -$598K – 753
2025
Q1 		$598K Buy
32,900
+200
+0.6% +$13.5K 0.06% 165
2024
Q4 		$768K Buy
32,700
+1,000
+3% +$67K 0.07% 155
2024
Q3 		$625K Sell
31,700
-14,300
-31% -$1.2M 0.07% 164
2024
Q2 		$38.6K Buy
+46,000
New +$3.83M ﹤0.01% 479
2023
Q3 		– Sell
-10,600
Closed -$38.5K – 1055
2023
Q2 		$38.5K Buy
+10,600
New +$998K 0.01% 551
2021
Q3 		– Sell
-13,000
Closed -$101K – 2446
2021
Q2 		$101K Sell
13,000
-15,400
-54% -$1.22M ﹤0.01% 1216
2021
Q1 		$173K Buy
28,400
+4,200
+17% +$343K 0.01% 803
2020
Q4 		$77K Sell
24,200
-2,200
-8% -$174K ﹤0.01% 1269
2020
Q3 		$164K Buy
+26,400
New +$2.67M 0.01% 684
2018
Q4 		– Sell
-226,500
Closed -$280K – 1135
2018
Q3 		$280K Sell
226,500
-1,200
-0.5% -$120K 0.02% 394
2018
Q2 		$690K Buy
+227,700
New +$19.9M 0.03% 287
2018
Q1 		– Sell
-58,100
Closed -$63K – 948
2017
Q4 		$63K Buy
+58,100
New +$5.05M ﹤0.01% 632
2017
Q1 		– Sell
-101,100
Closed -$94K – 1053
2016
Q4 		$94K Buy
101,100
+89,300
+757% +$7.68M ﹤0.01% 574
2016
Q3 		$28K Sell
11,800
-34,300
-74% -$3.23M ﹤0.01% 794
2016
Q2 		$59K Buy
+46,100
New +$3.92M ﹤0.01% 585
2015
Q4 		– Sell
-16,100
Closed -$505K – 963
2015
Q3 		$505K Buy
+16,100
New +$2.15M 0.03% 371

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HAP Trading's BMRN Position: Q2 2025 in Review

HAP Trading sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2025, closing a stake of 11,634 shares — an estimated $822K sold.

HAP Trading first reported a position in BMRN in Q4 2016 and held it in 15 quarters. The position peaked at $7.56M in Q2 2018. 582 funds tracked by Wall St. Rank hold BMRN as of Q2 2025.

  • HAP Trading reported no remaining BioMarin Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • HAP Trading sold 11,634 BioMarin Pharmaceuticals shares in Q2 2025, an estimated $822K.
  • HAP Trading first reported a position in BioMarin Pharmaceuticals in Q4 2016 and held it in 15 quarters.
  • HAP Trading's BioMarin Pharmaceuticals position peaked at $7.56M in Q2 2018.
  • 582 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2025.

Based on HAP Trading's 13F filing for Q2 2025, filed 13 Aug 2025.